UNSPSC 51411600: Vasodilator alcohols

Vasodilator drugs made from alkyl compounds containing a hydroxyl group

UNSPSC 51411600 Vasodilator alcohols is a Class code that encompasses emergency and acute-care medications supplied to fire rescue, emergency medical services, and state health and human services programs. State and local governments procure these medications as direct goods through competitive bidding and cooperative purchasing vehicles, with suppliers required to meet expiration-date standards, product-quality warranties, and regulatory compliance including Safety Data Sheets and FDA manufacturing certifications. Issuing bodies include city fire departments and emergency services, state health agencies, and multistate cooperative purchasing alliances. The City of Tampa Fire Rescue and the Texas Health and Human Services Commission represent the primary issuing bodies visible in recent activity, with Tampa using sealed competitive bidding for goods procurement and Texas conducting market-intelligence RFIs prior to formal sourcing.

Activity concentrates in Florida and Texas, with secondary multistate activity through Minnesota's MMCAP cooperative vehicle serving Oregon and other member jurisdictions. The City of Tampa issued IFB 26P00188 on April 24, 2026, with a response deadline of April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026, with a response deadline the same day, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program focused on establishing direct relationships between state pharmacy benefit programs and manufacturers outside traditional PBM and wholesaler channels. The Minnesota Department of Administration's MMCAP issued RFP S1070000015802 on January 20, 2026, with responses due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract terms effective July 1, 2026, and performance penalties of $200 to $1,500 per violation for late reporting or noncompliance.